wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41619667-BAECAAA9-D253-4A9E-8A11-A6302867FBD7
Q41619667-BAECAAA9-D253-4A9E-8A11-A6302867FBD7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41619667-BAECAAA9-D253-4A9E-8A11-A6302867FBD7
Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells.
P2860
Q41619667-BAECAAA9-D253-4A9E-8A11-A6302867FBD7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41619667-BAECAAA9-D253-4A9E-8A11-A6302867FBD7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
75285b40dd48882e89492b03ecd6a4918cb44975
P2860
Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer.